Initial findings into 'adverse event' did not necessitate halting of trials: Govt

The initial findings into the 'adverse event' allegedly suffered by an Oxford COVID-19 vaccine trial participant in Chennai did not necessitate halting of the trials, the Centre said on Tuesday. It is the role of drug regulator to ascertain or refute if there is any causal link between the event and the intervention, it said.

Read Full Story>>